SYNTHESIS, CHARACTERIZATION, AND ANTICANCER ACTIVITY OF 1,2,3-TRIAZOLE-DERIVED 1,3,4-OXADIAZOLE CONTAINING N-HETEROCYCLIC MOIETIES

被引:0
|
作者
Narsimha, Sirassu [1 ]
Lavudya, Sudhakar [1 ]
Hussain, Althaf S. K. [2 ]
Reddy, N. Vasudeva [1 ]
机构
[1] Kakatiya Univ, Dept Chem, Warangal 506009, TS, India
[2] Kakatiya Univ, Dept Biotechnol, Warangal 506009, TS, India
来源
HETEROCYCLIC LETTERS | 2015年 / 5卷 / 04期
关键词
1,2,3-triazole; Oxadiazole: N-heterocyclic compounds; Anticancer activity;
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
1,4-Disubstituted 1,2,3-triazoles (3a-3j) have been synthesized by one pot [3+2] cycloaddition reaction of 2-(azidomethyl)-5-phenyl-1,3,4-oxadiazole(1) with propargyl bromide and N-heterocyclic compounds (2a-j), respectively. The compounds were evaluated for in vitro anticancer activity against two human cancer cell lines MCF-7 and HeLa. Cisplatin used as a standard drug. Compound 3h has exhibited excellent activity against MCF-7 (IC50 16.93 mu M) than the standard drug Cisplatin. Compound 3j against HeLa (15.97 mu M) have also shown good activity. Remaining compounds have shown moderate to good anticancer activity against both cell lines.
引用
收藏
页码:653 / 660
页数:8
相关论文
共 50 条
  • [1] Evaluation of anticancer activity of some 1,3,4-oxadiazole derivatives
    Sengupta, Pinaki
    Dash, Deepak Kurnar
    Yeligar, Veerendra C.
    Murugesh, K.
    Rajalingarn, D.
    Singh, Jagadish
    Maity, T. K.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2008, 47 (03): : 460 - 462
  • [2] Synthesis of Indole-1,3,4-Oxadiazole Based Sulfonyl 1,2,3-Triazoles as Potent Anticancer and EGFR Inhibitors
    Jagan Mohan Reddy Velidandla
    Shiva Kumar Koppula
    Russian Journal of Bioorganic Chemistry, 2023, 49 : 1337 - 1345
  • [3] Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety
    Ragab, Fatma A. F.
    Abou-Seri, Sahar M.
    Abdel-Aziz, Salah A.
    Alfayomy, Abdallah M.
    Aboelmagd, Mohamed
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 140 - 151
  • [4] Synthesis of Indole-1,3,4-Oxadiazole Based Sulfonyl 1,2,3-Triazoles as Potent Anticancer and EGFR Inhibitors
    Velidandla, Jagan Mohan Reddy
    Koppula, Shiva Kumar
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2023, 49 (06) : 1337 - 1345
  • [5] Synthesis of Indole-1,3,4-oxadiazole Based Sulfonyl 1,2,4-Oxadiazole Derivatives as EGFR Targeting Anticancer Agents
    Dubba, Abhilasha
    Koppula, Shiva Kumar
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2023, 93 (11) : 2866 - 2873
  • [6] Synthesis of Indole-1,3,4-oxadiazole Based Sulfonyl 1,2,4-Oxadiazole Derivatives as EGFR Targeting Anticancer Agents
    Abhilasha Dubba
    Shiva Kumar Koppula
    Russian Journal of General Chemistry, 2023, 93 : 2866 - 2873
  • [7] Design, synthesis, characterization, molecular docking studies and anticancer activity evaluation of novel hydrazinecarbothioamide, 1,2,4-triazole-3-thione, 4-thiazolidinone and 1,3,4-oxadiazole derivatives
    Dincel, Efe Dogukan
    Akdag, Cigdem
    Kayra, Tulay
    Cosar, Ebru Didem
    Aksoy, Mehmet Onur
    Akalin-Ciftci, Gulsen
    Ulusoy-Guzeldemirci, Nuray
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1268
  • [8] Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,3-triazole incorporated 1,3,4-oxadiazole-Triazine derivatives
    Oggu, Sujana
    Akshinthala, Parameswari
    Katari, Naresh Kumar
    Nagarapu, Laxmi Kumari
    Malempati, Srimannarayana
    Gundla, Rambabu
    Jonnalagadda, Sreekantha Babu
    HELIYON, 2023, 9 (05)
  • [9] Synthesis, telomerase inhibitory and anticancer activity of new 2-phenyl-4H-chromone derivatives containing 1,3,4-oxadiazole moiety
    Han, Xu
    Yu, Yun Long
    Ma, Duo
    Zhang, Zhao Yan
    Liu, Xin Hua
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 344 - 360
  • [10] Novel 1,3,4-Oxadiazole Fused Thiadiazole Derivatives: Synthesis and Study of Anticancer Activities
    Spandana, Zanjam
    Sreenivasulu, Reddymasu
    MalathiRekha, Tadigiri
    Rao, Mandava Venkata Basaveswara
    LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 16 (06) : 656 - 662